Literature DB >> 10773192

Morphine-induced suppression of saccharin intake is correlated with elevated corticosterone levels.

F Gomez1, N A Leo, P S Grigson.   

Abstract

Rats suppress intake of a saccharin conditioned stimulus (CS) when paired with a drug of abuse. This phenomenon, however, is not uniform across all subjects and is greater following exposure to stress and in animals that more readily self-administer drugs of abuse. The present study was designed to examine these individual differences in intake suppression following seven saccharin-morphine pairings. Plasma corticosterone also was evaluated both before and after conditioning in order to determine whether the magnitude of CS suppression is, or is not, related to circulating corticosterone levels. The findings indicated that, while all rats were exposed to the same number of saccharin-morphine pairings, only half of these animals actually suppressed intake of the saccharin CS. Moreover, the results showed that greater suppression of CS intake was associated with higher corticosterone levels at test (r=-0.84, P<0.0001). Taken together, the results demonstrate that individual differences affect not only the reduction in CS intake following taste-drug pairings, but also the associated cue-induced elevation in circulating corticosterone.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10773192     DOI: 10.1016/s0006-8993(00)02093-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  20 in total

1.  Drug-motivated behavior in rats with lesions of the thalamic orosensory area.

Authors:  Jennifer E Nyland; Danielle N Alexander; Patricia S Grigson
Journal:  Behav Neurosci       Date:  2015-12-14       Impact factor: 1.912

2.  Reward Comparison: The Achilles' heel and hope for addiction.

Authors:  Patricia Sue Grigson
Journal:  Drug Discov Today Dis Models       Date:  2008

3.  Fischer rats are more sensitive than Lewis rats to the suppressive effects of morphine and the aversive kappa-opioid agonist spiradoline.

Authors:  Christopher S Freet; Robert A Wheeler; Ellen Leuenberger; Nicole A S Mosblech; Patricia S Grigson
Journal:  Behav Neurosci       Date:  2013-10       Impact factor: 1.912

4.  Adolescent rats fail to demonstrate a LiCl-induced pre-exposure effect: Implications for the balance of drug reward and aversion in adolescence.

Authors:  Matthew M Clasen; Bradley B Wetzell; Anthony L Riley
Journal:  Learn Behav       Date:  2016-12       Impact factor: 1.986

5.  Ontogenetic differences in sensitivity to LiCl- and amphetamine-induced taste avoidance in preweanling rats.

Authors:  Damián Alejandro Revillo; Norman E Spear; Carlos Arias
Journal:  Chem Senses       Date:  2011-03-28       Impact factor: 3.160

6.  The role of dose and restriction state on morphine-, cocaine-, and LiCl-induced suppression of saccharin intake: A comprehensive analysis.

Authors:  Robert C Twining; Christopher S Freet; Robert A Wheeler; Christian G Reich; Dennie A Tompers; Sarah E Wolpert; Patricia S Grigson
Journal:  Physiol Behav       Date:  2016-04-13

7.  Once is too much: conditioned aversion develops immediately and predicts future cocaine self-administration behavior in rats.

Authors:  Elizabeth M Colechio; Caesar G Imperio; Patricia S Grigson
Journal:  Behav Neurosci       Date:  2014-04       Impact factor: 1.912

Review 8.  The state of the reward comparison hypothesis: theoretical comment on Huang and Hsiao (2008).

Authors:  Patricia Sue Grigson
Journal:  Behav Neurosci       Date:  2008-12       Impact factor: 1.912

9.  Prior access to a sweet is more protective against cocaine self-administration in female rats than in male rats.

Authors:  Angie M Cason; Patricia S Grigson
Journal:  Physiol Behav       Date:  2013-03-06

10.  Greater avoidance of a heroin-paired taste cue is associated with greater escalation of heroin self-administration in rats.

Authors:  Caesar G Imperio; Patricia S Grigson
Journal:  Behav Neurosci       Date:  2015-08       Impact factor: 1.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.